An Vermeulen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Systematic Review

Hyaluronic Acid

Ulcerative Colitis

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Louis Sandra, Huybrecht T'jollyn, An Vermeulen, Oliver Ackaert, Juan Jose Perez Ruixo
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice. CPT: pharmacometrics & systems pharmacology (2024)
Louis Sandra, Huybrecht T'jollyn, An Vermeulen, Oliver Ackaert, Juan Jose Perez Ruixo
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics (2024)
Louis Sandra, Huybrecht T'jollyn, An Vermeulen, Oliver Ackaert, Juan Jose Perez Ruixo
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Louis Sandra, Huybrecht T'jollyn, An Vermeulen, Oliver Ackaert, Juan Jose Perez Ruixo
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Louis Sandra, Huybrecht T'jollyn, An Vermeulen, Oliver Ackaert, Juan Jose Perez Ruixo
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Louis Sandra, Huybrecht T'jollyn, An Vermeulen, Oliver Ackaert, Juan Jose Perez Ruixo
Model-based meta-analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B-infected mice. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Jie Shao, Marion Vetter, An Vermeulen, Brian G Feagan, Bruce E Sands, Julian Panes, Zhenhua Xu
Combination Therapy With Guselkumab and Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Pharmacokinetics, Immunogenicity and Drug-Drug Interactions. Clinical pharmacology and therapeutics 115 (6) (2024)
Pieter-Jan De Sutter, Maxime Van Haeverbeke, Eva Van Braeckel, Stephanie Van Biervliet, Jan Van Bocxlaer, An Vermeulen, Elke Gasthuys
Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data. CPT: pharmacometrics & systems pharmacology 11 (8) (2022)